Jagsonpal Pharmaceuticals Ltd. (IN:JAGSNPHARM)
:JAGSNPHARM
Total Valuation
Jagsonpal Pharmaceuticals Ltd. has a market cap or net worth of ₹12.92B. The enterprise value is ₹12.87B.
Market Cap₹12.92B
Enterprise Value₹12.87B
Share Statistics
Jagsonpal Pharmaceuticals Ltd. has 66,962,250 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding66,962,250
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Jagsonpal Pharmaceuticals Ltd.’s return on equity (ROE) is 0.23 and return on invested capital (ROIC) is 13.59%.
Return on Equity (ROE)0.23
Return on Assets (ROA)0.20
Return on Invested Capital (ROIC)13.59%
Return on Capital Employed (ROCE)0.17
Revenue Per Employee2.62M
Profits Per Employee540.11K
Employee Count1,025
Asset Turnover0.97
Inventory Turnover6.34
Valuation Ratios
The current PE Ratio of Jagsonpal Pharmaceuticals Ltd. is 28.8. Jagsonpal Pharmaceuticals Ltd.’s PEG ratio is 0.18.
PE Ratio28.8
PS Ratio5.44
PB Ratio6.09
Price to Fair Value6.09
Price to FCF26.60
Price to Operating Cash Flow50.71
PEG Ratio0.18
Income Statement
In the last 12 months, Jagsonpal Pharmaceuticals Ltd. had revenue of 2.69B and earned 553.61M in profits. Earnings per share was 8.26.
Revenue2.69B
Gross Profit1.72B
Operating Income435.49M
Pretax Income698.59M
Net Income553.61M
EBITDA510.71M
Earnings Per Share (EPS)8.26
Cash Flow
In the last 12 months, operating cash flow was 246.75M and capital expenditures -980.00K, giving a free cash flow of 245.77M billion.
Operating Cash Flow246.75M
Free Cash Flow245.77M
Free Cash Flow per Share3.67
Dividends & Yields
Jagsonpal Pharmaceuticals Ltd. pays an annual dividend of ₹2.5, resulting in a dividend yield of 1.24%
Dividend Per Share₹2.5
Dividend Yield1.24%
Payout Ratio26.82%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.05
52-Week Price Change-7.49%
50-Day Moving Average176.65
200-Day Moving Average211.49
Relative Strength Index (RSI)66.54
Average Volume (3m)3.85K
Important Dates
Jagsonpal Pharmaceuticals Ltd. upcoming earnings date is May 26, 2026, TBA (Confirmed).
Last Earnings DateJan 21, 2026
Next Earnings DateMay 26, 2026
Ex-Dividend Date―
Financial Position
Jagsonpal Pharmaceuticals Ltd. as a current ratio of 6.22, with Debt / Equity ratio of 3.49%
Current Ratio6.22
Quick Ratio5.64
Debt to Market Cap0.00
Net Debt to EBITDA-2.34
Interest Coverage Ratio45.46
Taxes
In the past 12 months, Jagsonpal Pharmaceuticals Ltd. has paid 144.98M in taxes.
Income Tax144.98M
Effective Tax Rate0.21
Enterprise Valuation
Jagsonpal Pharmaceuticals Ltd. EV to EBITDA ratio is 26.28, with an EV/FCF ratio of 24.43.
EV to Sales5.00
EV to EBITDA26.28
EV to Free Cash Flow24.43
EV to Operating Cash Flow24.27
Balance Sheet
Jagsonpal Pharmaceuticals Ltd. has ₹1.59B in cash and marketable securities with ₹88.36M in debt, giving a net cash position of ₹1.50B billion.
Cash & Marketable Securities₹1.59B
Total Debt₹88.36M
Net Cash₹1.50B
Net Cash Per Share₹22.47
Tangible Book Value Per Share₹22.92
Margins
Gross margin is 63.66%, with operating margin of 16.21%, and net profit margin of 20.60%.
Gross Margin63.66%
Operating Margin16.21%
Pretax Margin26.00%
Net Profit Margin20.60%
EBITDA Margin19.01%
EBIT Margin15.98%
Analyst Forecast
The average price target for Jagsonpal Pharmaceuticals Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast24.60%
EPS Growth Forecast153.56%